984 related articles for article (PubMed ID: 16054753)
101. Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset.
Parsian A; Racette B; Goldsmith LJ; Perlmutter JS
Genomics; 2002 Mar; 79(3):458-61. PubMed ID: 11863377
[TBL] [Abstract][Full Text] [Related]
102. A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease.
Licastro F; Chiappelli M; Grimaldi LM; Morgan K; Kalsheker N; Calabrese E; Ritchie A; Porcellini E; Salani G; Franceschi M; Canal N
Neurobiol Aging; 2005 Apr; 26(4):449-53. PubMed ID: 15653173
[TBL] [Abstract][Full Text] [Related]
103. Use of haplotype information to test involvement of the LRP gene in Alzheimer's disease in the French population.
Verpillat P; Bouley S; Campion D; Hannequin D; Dubois B; Belliard S; Puel M; Thomas-Antérion C; Agid Y; Brice A; Clerget-Darpoux F
Eur J Hum Genet; 2001 Jun; 9(6):464-8. PubMed ID: 11436129
[TBL] [Abstract][Full Text] [Related]
104. [Analysis on association between the polymorphisms in apolipoprotein E, interleukin-1 alpha genes and Alzheimer's disease in Chengdu area].
Tang MN; Zhang ZX; Han HY; Liu XH; Shen Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):176-8. PubMed ID: 15079806
[TBL] [Abstract][Full Text] [Related]
105. Apolipoprotein E promoter polymorphisms and risk of Alzheimer's disease: evidence from meta-analysis.
Xin XY; Ding JQ; Chen SD
J Alzheimers Dis; 2010; 19(4):1283-94. PubMed ID: 20061606
[TBL] [Abstract][Full Text] [Related]
106. [Gln192Arg polymorphism of the paraoxonase-1 gene is not associated with Alzheimer's disease in Chinese].
Shi JJ; Zhang SZ; Ma C; Tang MN; Liu XH; Wang YC; Han HY; Guo YB; Feng RM; Miao GD
Di Yi Jun Yi Da Xue Xue Bao; 2004 Apr; 24(4):371-4. PubMed ID: 15090300
[TBL] [Abstract][Full Text] [Related]
107. Genetic variation in the choline O-acetyltransferase gene in depression and Alzheimer's disease: the VITA and Milano studies.
Grünblatt E; Reif A; Jungwirth S; Galimberti D; Weber H; Scarpini E; Sauer C; Wichart I; Rainer MK; Huber K; Danielczyk W; Tragl KH; Deckert J; Fischer P; Riederer P
J Psychiatr Res; 2011 Sep; 45(9):1250-6. PubMed ID: 21507424
[TBL] [Abstract][Full Text] [Related]
108. A genome survey for novel Alzheimer disease risk loci: results at 10-cM resolution.
Zubenko GS; Hughes HB; Stiffler JS; Hurtt MR; Kaplan BB
Genomics; 1998 Jun; 50(2):121-8. PubMed ID: 9653640
[TBL] [Abstract][Full Text] [Related]
109. Polymorphisms of brain-derived neurotrophic factor associated with heroin dependence.
Jia W; Shi JG; Wu B; Ao L; Zhang R; Zhu YS
Neurosci Lett; 2011 May; 495(3):221-4. PubMed ID: 21458533
[TBL] [Abstract][Full Text] [Related]
110. Association study of the A2M and LRP1 Genes with Alzheimer disease in the Han Chinese.
Bian L; Yang JD; Guo TW; Duan Y; Qin W; Sun Y; Feng GY; He L
Biol Psychiatry; 2005 Nov; 58(9):731-7. PubMed ID: 16040006
[TBL] [Abstract][Full Text] [Related]
111. SREBP-1a polymorphism influences the risk of Alzheimer's disease in carriers of the ApoE4 allele.
Spell C; Kölsch H; Lütjohann D; Kerksiek A; Hentschel F; Damian M; von Bergmann K; Rao ML; Maier W; Heun R
Dement Geriatr Cogn Disord; 2004; 18(3-4):245-9. PubMed ID: 15286454
[TBL] [Abstract][Full Text] [Related]
112. [Analysis of clusterin gene (CLU/APOJ) polymorphism in Alzheimer's disease patients and in normal cohorts from Russian populations].
Golenkina SA; Gol'tsov AIu; Kuznetsova IL; Grigorenko AP; Andreeva TV; Reshetov DA; Kunizheva SS; Shagam LI; Morozova IIu; Goldenkova-Pavlova IV; Shimshilashvili Kh; Viacheslavova AO; Faskhutdinova G; Gareeva AÉ; Zaĭnullina AG; Khusnutdinova ÉK; Puzyrev VP; Stepanov VA; Kolotvin AV; Samokhodskaia LM; Selezneva ND; Gavrilova SI; Rogaev EI
Mol Biol (Mosk); 2010; 44(4):620-6. PubMed ID: 20873220
[TBL] [Abstract][Full Text] [Related]
113. Methionine synthase polymorphism is a risk factor for Alzheimer disease.
Beyer K; Lao JI; Latorre P; Riutort N; Matute B; Fernández-Figueras MT; Mate JL; Ariza A
Neuroreport; 2003 Jul; 14(10):1391-4. PubMed ID: 12876480
[TBL] [Abstract][Full Text] [Related]
114. Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women.
Pirskanen M; Hiltunen M; Mannermaa A; Helisalmi S; Lehtovirta M; Hänninen T; Soininen H
Eur J Hum Genet; 2005 Sep; 13(9):1000-6. PubMed ID: 15944651
[TBL] [Abstract][Full Text] [Related]
115. A haplotype of the methylenetetrahydrofolate reductase gene is protective against late-onset Alzheimer's disease.
Wakutani Y; Kowa H; Kusumi M; Nakaso K; Yasui K; Isoe-Wada K; Yano H; Urakami K; Takeshima T; Nakashima K
Neurobiol Aging; 2004 Mar; 25(3):291-4. PubMed ID: 15123333
[TBL] [Abstract][Full Text] [Related]
116. No evidence for association of the monocyte chemoattractant protein-1 (-2518) gene polymorphism and Alzheimer's disease.
Combarros O; Infante J; Llorca J; Berciano J
Neurosci Lett; 2004 Apr; 360(1-2):25-8. PubMed ID: 15082170
[TBL] [Abstract][Full Text] [Related]
117. Association of a variation in the promoter region of the brain-derived neurotrophic factor gene with familial Parkinson's disease.
Parsian A; Sinha R; Racette B; Zhao JH; Perlmutter JS
Parkinsonism Relat Disord; 2004 Jun; 10(4):213-9. PubMed ID: 15120095
[TBL] [Abstract][Full Text] [Related]
118. Association study of the chemokine, CXC motif, ligand 1 (CXCL1) gene with sporadic Alzheimer's disease in a Japanese population.
Tamura Y; Sakasegawa Y; Omi K; Kishida H; Asada T; Kimura H; Tokunaga K; Hachiya NS; Kaneko K; Hohjoh H
Neurosci Lett; 2005 May; 379(3):149-51. PubMed ID: 15843053
[TBL] [Abstract][Full Text] [Related]
119. Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred.
Pastor P; Roe CM; Villegas A; Bedoya G; Chakraverty S; García G; Tirado V; Norton J; Ríos S; Martínez M; Kosik KS; Lopera F; Goate AM
Ann Neurol; 2003 Aug; 54(2):163-9. PubMed ID: 12891668
[TBL] [Abstract][Full Text] [Related]
120. Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type.
Ribasés M; Gratacòs M; Armengol L; de Cid R; Badía A; Jiménez L; Solano R; Vallejo J; Fernández F; Estivill X
Mol Psychiatry; 2003 Aug; 8(8):745-51. PubMed ID: 12888803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
